Sir.—Cases of mucocutaneous lymph node syndrome (MLNS) appearing in Arizona, California, Florida, Hawaii, Iowa, New York, Tennessee, and Washington, DC, have been reported to the Center for Disease Control.1 We have recently observed a patient in Maryland whose clinical course was consistent with the criteria accepted for MLNS.1-6
Report of a Case.—During October 1975, a 19-month-old boy developed a high fever that persisted for 15 days despite penicillin and erythromycin therapy. A generalized maculopapular rash accompanied by pharyngeal inflammation and cervical adenitis appeared two days after the onset of the fever. At the time of hospitalization on the 13th day of illness, a temperature of 40 C, bilateral conjunctivitis, generalized lymphadenopathy, oropharyngeal erythema, a scarlatiniform rash, and desquamation of the fingertips and toes were noted. Throat and nasal cultures showed normal flora. The WBC count was 14,400/cu mm, with 62% granulocytes. Corticosteroid therapy (used in the
WALKER SH, QUINTERO BA, HELDRICH FJ. Mucocutaneous Lymph Node Syndrome. Am J Dis Child. 1976;130(10):1164. doi:10.1001/archpedi.1976.02120110126025
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.